All nominations are assessed by an independent, multidisciplinary panel.
We introduce them below.
JOLIEN PON, PATIENT ADVOCATE FOR BOWEL CANCER
Jolien Pon ran her own business for more than 20 years, involved in multidisciplinary treatment of people with obesity. She retired in 2012. She was diagnosed in 2008 with Stage III colorectal cancer, which had spread to the lymph nodes. She has undergone surgery twice, and 8 chemotherapy cycles.
Jolien was chair of the Netherlands Bowel Cancer group from 2010 to 2016. She is currently very active in the new Bowel Cancer Working Group, part of the Stoma Association. She is also part of the PAG (Patient Advisory Group) for EuropaColon (DiCE).
JAN MOL, BOARD MEMBER, HEMATON FOUNDATION (PATIENT ORGANISATION FOR LEUKAEMIA, LYMPHOMA AND STEM CELL TRANSPLANTATION)
Dr. Ir. Jan A. Mol (1954) is a cellular biologist who leads a research group on comparative and translational oncology at Utrecht University. He also sits on the board at the Hematon Foundation, responsible for the lobbying committee. Hematon looks after the interests of patients with leukaemia, lymphoma and stem cell transplantation.
TINEKE A.W. DUIJTS, CLINICAL NURSE SPECIALIST
MEDISCH SPECTRUM TWENTE
Mrs Tineke Duyts obtained her A-Nursing qualification in 1978.
Throughout her career, she advanced continually through middle and senior management, and as an oncology nurse. In 1998, she obtained Certificates of Competence for her BIG-registration, and has been a registered clinical nurse specialist since 2012, for intensive care with somatic disorders. She is an intensive care clinical nurse specialist for haematology at the MST in Enschede. Her areas of focus are acute and chronic leukaemia, lymphomas, multiple myeloma (Kahler's disease) and stem cell transplantation. In addition to her work as a clinical nurse specialist, she has numerous other positions, being, for example, a HOVON protocol committee member, medical ethics review committee member , ATHOC member (Achterhoek-Twente haemato-oncology committee), TWG Haematology member, and programme committee member for the DHC (Dutch Haematology Congress). She is additionally part of various multidisciplinary teams. She also has nearly 10 published articles to her name, and is working on various trials.
JOSE M.J. SCHELLEKENS- VAN BRONSWIJK, CLINICAL NURSE SPECIALIST
Mrs. José Schellekens obtained her A-Nursing qualification in 1982. She had held various positions during the course of her career, when in 1998 she chose cancer patient care. She trained in cancer care, and became an oncology nurse coordinator at the internal medicine outpatient clinic at the then Lievensberg hospital in Bergen op Zoom. She was closely involved in developments in cancer patient care. A few years later she trained as a clinical nurse specialist. The Lievensberg hospital became Bravis hospital, and she has been working in the Oncology Centre at the Roosendaal site since November, 2016, as a clinical nurse specialist and research coordinator. She supports breast and bowel cancer patients who are having supplementary chemotherapy treatment. She is also involved as research coordinator, carrying out medical scientific research, and supervising patients involved in these studies.
MONIQUE C. MINNEMA, HAEMATOLOGIST
UTRECHT UNIVERSITY MEDICAL CENTER (UMCU)
Dr. Monique Minnema trained as an internist and haematologist at the AMC (Academic Medical Centre), Amsterdam and the University Medical Center, Utrecht. She has worked at the department of haematology at the UMC Utrecht Cancer Center since 2005. She specialises in treating lymphomas and plasma cell diseases such as multiple myeloma and AL amyloidosis.
As well as specialising in the above conditions, she is head of the haematology study team, and local or principal investigator for more than 20 clinical trials, including early-phase trials of daratumumab in recurrent multiple myeloma, and anti CD19 CAR T cell studies in relapsed non-Hodgkin lymphoma.
Her particular interest is in the development of novel therapies such as immunotherapy and targeted "personalised" treatment for B cell malignancies, where she is working with researcher Victor Peperzak.
MARIJA TRAJKOVIC-VIDAKOVIC, ONCOLOGIST
ALBERT SCHWEITZER HOSPITAL (ASZ)
Dr. Marija Trajkovic graduated with a first-class honours degree in medicine from the University of Antwerp in 2005. Her enthusiasm for internal medicine, and more specifically, oncology, came about while studying internal medicine at the Sint Antonius Hospital in Nieuwegein. She completed her training as internist and oncologist at the UMC Utrecht. She is very pleased to have been working at the Albert Schweitzer Hospital since 2014, looking after cancer patients. Her heart lies in strong support and state-of-the-art treatment for cancer patients. She also believes that communication lies at the core of success for people facing one of the most difficult moments in their life.
Her special area of focus within oncology is colorectal carcinomas (colon and rectum cancer), where care pathways and clinical scientific studies, among others, play an important role. Optimum treatment for each patient is worked out through shared decision making.